Illicit substance use and opioid misuse in adolescent and young adult (AYA) patients with cancer.

• DOI: 10.1200/jco.2017.35.31_suppl.205
• Publication Date: 2017-11-14T19:00:59Z
• Authors: Ritika Oberoi-Jassal; Young Doo Chang; Joshua Smith; Sahana Rajasekhara; Vijay Desai; Alyssa L Fenech; Damon R. Reed; Diane Portman; Kristine A. Donovan
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

205 Background: Rates of illicit substance use and misuse opioid medications are high in the adolescent young adult (AYA) general population. Despite this, screening for is not standard care AYA oncology supportive/palliative care. To inform our clinical practice, we sought to determine prevalence potential cancer patients relative examine correlates misuse. Methods: We conducted retrospective chart review newly referred an outpatient palliative clinic between 2014 2016. Results: Consecutive (N = 963) underwent urine drug testing as part their initial visit; 16% were 18 39 years age. Rate was 31% AYAs 19% adults. nearly 2 times more likely have positive results marijuana (OR 1.79; 95% CI 1.19 – 2.69) 3 test amphetamines 2.94; 1.15 7.49). no than adults cocaine, barbiturates or heroin. In univariate analyses, only male sex being single, characteristics symptom scores, significantly associated with (ps < .05). presence opioids, currently prescribed 1.07; 0.70 1.65). No symptoms scores demographic Conclusions: demonstrated a rate similar patients. Findings suggest may benefit from consistent screening, support treatment during anticancer cancer-related therapies.